Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis.
Saved in:
| Title: | Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis. |
|---|---|
| Authors: | Kosloski MP; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. matthew.kosloski@regeneron.com., Lai CH; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Partridge MA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Kanamaluru V; Sanofi, Morristown, NJ, USA., Bansal A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Shumel B; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Ardeleanu M; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Yan H; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Xu C; Sanofi, Morristown, NJ, USA., Marco AR; Sanofi, Madrid, Spain., Xiao J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Khokhar FA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Gherardi G; Sanofi, Reading, UK., Babilonia E; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Akinlade B; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Torri A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Davis JD; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. |
| Source: | Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jun; Vol. 16 (6), pp. 2603-2606. Date of Electronic Publication: 2026 Apr 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8210 |
|---|---|
| DOI: | 10.1007/s13555-026-01750-w |
